| European S2k Guideline on Chronic Pruritus In cooperation with the European Dermatology Forum (EDF) and the European Academy of Dermatology and Venereology (EADV) |
26 |
| Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa |
19 |
| Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis |
18 |
| Chronic Prurigo of Nodular Type: A Review |
18 |
| Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study |
16 |
| Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study |
15 |
| Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis |
13 |
| Epidemiology and Medication Trends in Patients with Psoriasis: A Nationwide Population-based Cohort Study from Korea |
13 |
| Role of the Gut Microbiota in Atopic Dermatitis: A Systematic Review |
12 |
| Melanogenesis Inhibitors |
12 |
| Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review |
12 |
| Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries |
12 |
| Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis |
12 |
| The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization |
11 |
| Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden |
11 |
| Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid |
11 |
| Skin Cancer Associated Genodermatoses: A Literature Review |
11 |
| Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment |
11 |
| Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis |
10 |
| Atypical Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6 in Denmark: A Diagnostic Mimicker |
10 |
| Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back |
10 |
| Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor |
9 |
| Occurrence, Chronicity and Intensity of Itch in a Clinical Consecutive Sample of Patients with Skin Diseases: A Multi-centre Study in 13 European Countries |
9 |
| Effect of Age on Melanoma Risk, Prognosis and Treatment Response |
9 |
| Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment |
8 |
| Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls |
8 |
| Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU) |
8 |
| Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis |
8 |
| Burden of Atopic Dermatitis in Swedish Adults: A Population-based Study |
8 |
| Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature |
8 |
| Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid |
8 |
| Skin Barrier Damage and Itch: Review of Mechanisms, Topical Management and Future Directions |
7 |
| Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines |
7 |
| Influence of Itch and Pain on Sleep Quality in Patients with Hidradenitis Suppurativa |
7 |
| Actinic Cheilitis Prevalence and Risk Factors: A Cross-sectional, Multicentre Study in a Population Aged 45 Years and Over in North-west Spain |
7 |
| Treatment of Cutaneous Pseudolymphoma: A Systematic Review |
7 |
| Sub-optimal Application of a High SPF Sunscreen Prevents Epidermal DNA Damage in Vivo |
7 |
| Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis |
6 |
| IL-17A Inhibitor Switching - Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience |
6 |
| Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006-2015 |
6 |
| Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy |
6 |
| Autochthonous Cutaneous Larva Migrans in France and Europe |
6 |
| Interest in Skin Cancer in Urban Populations: A Retrospective Analysis of Google Search Terms in Nine Large German Cities |
6 |
| Antioxidative Phytochemicals Accelerate Epidermal Terminal Differentiation via the AHR-OVOL1 Pathway: Implications for Atopic Dermatitis |
6 |
| Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden |
6 |
| Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naive CD4 T Lymphocytes in Mice |
6 |
| Granuloma Faciale Treatment: A Systematic Review |
6 |
| Significant Changes in the Skin Microbiome in Patients with Chronic Plaque Psoriasis after Treatment with Narrowband Ultraviolet B |
6 |
| Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis |
6 |
| The Association Between Low Grade Systemic Inflammation and Skin Diseases: A Cross-sectional Survey in the Northern Finland Birth Cohort 1966 |
6 |
